2/21/2024 | CV | Market Commentary: Floodgates open; Super Micro, Lyft, Sunrun, Parsons on tap; Global Payments jumps
|
9/1/2023 | CV | Globus, NuVasive amend terms for $450 million 0.375% convertibles
|
5/26/2023 | CVLM | NuVasive draws on revolver to repay $450 million 1% convertibles
|
6/4/2020 | CV | NuVasive greenshoe ups three-year convertible notes to $450 million
|
5/28/2020 | CV | Market Commentary: Bilibili, Cerence convertibles eyed; Datadog upsizes; Air Canada, Silicon Labs expand
|
5/28/2020 | CV | Market Commentary: Morning Commentary: Bilibili, Cerence, Datadog eyed; new deals make aftermarket debut
|
5/28/2020 | CV | New Issue: NuVasive prices $400 million three-year convertible notes to yield 1%, up 32.5%
|
5/27/2020 | CV | Market Commentary: Bilibili, Cerence on tap; Silicon Labs, NuVasive, Air Canada eyed; 1Life Healthcare down
|
5/27/2020 | CV | Market Commentary: Morning Commentary: Silicon Labs, NuVasive, Air Canada eyed; 1Life Healthcare upsizes
|
5/26/2020 | CV | Market Commentary: Nuvasive, Air Canada on tap; 1Life Healthcare eyed; Southwest, Pioneer Natural gain
|
5/26/2020 | CV | NuVasive talks $400 million three-year convertible notes to yield 0.75%-1.25%, up 32.5%-37.5%
|
2/28/2020 | CV | Market Commentary: RingCentral prices $1 billion, contracts on debut; Exact Sciences, NuVasive down again
|
2/27/2020 | CV | Market Commentary: RingCentral on tap; NuVasive contracts on debut; Bandwidth, Exact Sciences below par
|
2/27/2020 | CV | Market Commentary: Morning Commentary: RingCentral offers $1 billion convertibles; NuVasive below par
|
2/27/2020 | CV | New Issue: NuVasive prices $450 million five-year convertible notes to yield 0.375%, up 35%
|
2/26/2020 | CV | Market Commentary: NuVasive convertible offering eyed; Bandwidth expands on debt; Exact Sciences volatile
|
2/26/2020 | CV | Market Commentary: Morning Commentary: Bandwidth convertibles expand on debt; NuVasive offering eyed
|
2/26/2020 | CV | NuVasive talks $450 million five-year convertible notes to yield 0.375%-0.875%, up 32.5%-37.5%
|
2/21/2020 | CV | Market Commentary: NuVasive convertible notes in focus, up on swap; Avadel skyrockets; Pegasystems active
|
2/21/2020 | CV | Market Commentary: Morning Commentary: NuVasive convertible notes in focus, up on swap in early trading
|
2/11/2019 | CV | Market Commentary: NuVasive convertibles in focus on buyout talk; Euronet active; SolarCity notes improve
|
2/11/2019 | CV | Market Commentary: Morning Commentary: NuVasive convertibles in focus on buyout talk; Euronet notes jump
|
7/28/2017 | CV | Market Commentary: NuVasive drops outright but gains on swap; Intel in line after posting positive earnings
|
7/28/2017 | CV | Market Commentary: Morning Commentary: NuVasive sinks after results disappoint; Intel in line after positive earnings
|
11/28/2016 | CVLM | NuVasive buys back $49.6 million of 2.75% convertibles due 2017
|
10/26/2016 | CV | Market Commentary: Weatherford pressured by earnings; Akamai firms; NuVasive takes a hit; Dycom up on swap
|
5/2/2016 | CV | Market Commentary: GNC trades up on possible sale; Whiting mostly quiet after earnings disappoint; Cobalt up
|
4/27/2016 | CV | Market Commentary: NuVasive flat on swap after positive quarter; Twitter slips as stock drops; Knowles on tap
|
3/16/2016 | CV | NuVasive greenshoe exercised, ups 2.25% convertibles to $650 million
|
3/14/2016 | CV | Market Commentary: SanDisk trades ahead of anticipated deal; NuVasive extends gains after strong debut
|
3/14/2016 | CV | Market Commentary: Morning Commentary: Starwood Property, Colony edge up; older NuVasive moves higher
|
3/11/2016 | CV | Market Commentary: New NuVasive jumps on swap in active trade; older NuVasive adds a point; energy gains
|
3/11/2016 | CV | Market Commentary: Morning Commentary: New NuVasive convertible jumps in active trade; older NuVasive up slightly
|
3/11/2016 | CV | New Issue: NuVasive prices $550 million five-year convertible notes to yield 2.25%, up 32.5%
|
3/10/2016 | CV | Market Commentary: Unisys, CSG Systems gain outright, on swap with lower shares; planned NuVasive looks cheap
|
3/9/2016 | CV | Market Commentary: Three deals launch in convertibles market; Unisys is 100.25 bid; CSG Systems looks cheap
|
3/9/2016 | CV | NuVasive to price $550 million five-year convertible notes to yield 2.25%-2.75%, up 30%-35%
|
4/2/2015 | CV | Market Commentary: New Trinity Biotech quiet, shares lower; overall market muted ahead of holiday weekend
|
1/15/2014 | CV | Market Commentary: JinkoSolar's planned $100 million convertibles looks cheap; SunEdison adds; NuVasive jumps
|
7/31/2013 | CV | Market Commentary: Convertibles trade sideways, better amid unchanged Fed policy; NuVasive down; Meritor up
|
10/24/2012 | CV | Market Commentary: NuVasive trades flattish as shares jump; Navistar gains as shares slip; EMC paper active
|
10/4/2012 | CV | Market Commentary: New Ares Capital flat after pricing at discount; WellPoint gains; NuVasive loses on hedge
|
10/3/2012 | CV | Market Commentary: New WellPoint up on debut; Ares Capital on tap; existing Ares paper quiet; NuVasive drops
|
6/29/2012 | CV | Market Commentary: Convertibles strengthen: U.S. Steel, Navistar add on hedge; NuVasive up outright, new Gevo quiet
|
5/1/2012 | CV | Market Commentary: New NextEra edges up from sharp discount; Central European Media pops; NuVasive improves
|
2/23/2012 | CV | Market Commentary: Clearwire extends recent climb; Kodak active at lower pricing; Exterran up on earnings
|
2/22/2012 | CV | Market Commentary: Central European Media slips after disappointing earnings; MGIC adds; NuVasive in focus
|
1/26/2012 | CV | Market Commentary: NuVasive expands on hedge; Illumina 'in line' to slightly better; Petroplus steadier
|
1/25/2012 | CV | Market Commentary: Illumina 'rips' higher outright, expands on hedge; Life, Human Genome move in sympathy
|
1/11/2012 | CV | Market Commentary: New PHH surges out of the chute; existing PHH convertibles improve; NuVasive up on hedge
|
12/30/2011 | CV | Outlook 2012: Convertibles poised for modest gains after 2011's mostly negative returns
|
12/12/2011 | CVLM | NuVasive buys back $37 million of its 2.25% convertibles due 2013
|
11/30/2011 | CV | Market Commentary: Convertibles lag broader markets; AMR bounces a little; Lennar, Electronic Arts higher
|
10/28/2011 | CV | Market Commentary: Convertibles stronger post Euro debt deal, but in-the money names slip; MF Global lower
|
9/23/2011 | CV | Market Commentary: NuVasive seen as interesting story despite Medtronic issues; aircraft, airline space busy
|
9/22/2011 | CV | Market Commentary: NuVasive paper falls on jury verdict; Suntech weak; Hologic pressured by 'large seller'
|
9/21/2011 | CV | Market Commentary: Medtronic wins patent case against NuVasive; Human Genome gains; Alpha pulls down coal
|
8/15/2011 | CVLM | NuVasive buys back $118.7 million of 2.25% convertibles in past week
|
7/27/2011 | CV | Market Commentary: Accuray adds on debut; Alere falls after lowered forecast; DryShips convertibles for sale
|
7/26/2011 | CV | Market Commentary: BGC Partners flat on debut; RadioShack higher on Verizon link up; Kodak extends slide
|
6/30/2011 | CV | Market Commentary: Cemex adds 0.5 point delta neutral; Kodak poised ahead of ITC ruling; Superior Energy up
|
6/24/2011 | CV | Market Commentary: New Insulet adds on swap; purchases of older Insulet planned; NuVasive dips; Micron lower
|
6/23/2011 | CV | New Issue: NuVasive prices upsized $350 million six-year convertibles to yield 2.75%, up 30%
|
6/23/2011 | CV | Market Commentary: New NuVasive trades actively around par, adds on hedge; Jefferies flat on hedged basis
|
6/22/2011 | CV | Market Commentary: Planned NuVasive looks slightly cheap; existing NuVasive contracts; Insulet paper on tap
|
6/21/2011 | CVLM | NuVasive to buy back up to $230 million of 2.25% convertibles due 2013
|
6/21/2011 | CV | NuVasive's $325 million six-year convertible notes talked at 2.5%-3% coupon, up 27.5%-32.5%
|
6/21/2011 | CV | Market Commentary: Molycorp, Brookdale up; Boston Properties adds outright, slips on hedge; NuVasive on tap
|
12/17/2010 | CV | Market Commentary: InterMune gains outright; lighter delta yields better hedge move; MGIC, NuVasive active
|
2/26/2010 | CV | Market Commentary: Interpublic rises on earnings; NuVasive up on insurer support; Amylin gains with coverage
|
3/14/2008 | CV | NuVasive says greenshoe exercised in full, lifting sale of 2.25% convertibles to $230 million
|
3/4/2008 | CV | New Issue: NuVasive sells $200 million five-year convertibles to yield 2.25%, up 27.5%
|
3/4/2008 | CV | Market Commentary: Convertibles prices ease; market eyes Bill Barrett, Central Europe deals; Regal Entertainment to price
|
3/3/2008 | CV | Market Commentary: Convertibles market eyes new issues from NuVasive, Central European; Thornburg drops
|
3/3/2008 | CV | NuVasive $200 million five-year convertibles talked at 2.25%-2.75% coupon, up 22.5%-27.5%
|
3/3/2008 | CV | Market Commentary: Convertibles market eyes new issues from NuVasive, Central European; Thornburg drops
|